

# MCN · Barrier, Absorbable, Adhesion

_ ·  · Class 3_

**Canonical URL:** https://fda.innolitics.com/submissions/OB/OB-misc/MCN

## Overview

- **Product Code:** MCN
- **Device Name:** Barrier, Absorbable, Adhesion
- **Regulation:** 21 CFR N/A
- **Device Class:** 3
- **Review Panel:** [](/submissions/)

## Recent Cleared Devices (5 of 5)

| Record | Device Name | Applicant | Decision Date | Decision |
| --- | --- | --- | --- | --- |
| [P240015](https://fda.innolitics.com/submissions/OB/OB-misc/MCN/P240015.md) | Womed Leaf Resorbable Adhesion Barrier | Womed Sas | Sep 9, 2025 | APPR |
| [P050011](https://fda.innolitics.com/submissions/OB/OB-misc/MCN/P050011.md) | ADEPT (4% ICODEXTRIN) ADHESION REDUCTION SOLUTION | Baxter Healthcare Corp | Jul 28, 2006 | APPR |
| [P990015](https://fda.innolitics.com/submissions/OB/OB-misc/MCN/P990015.md) | INTERGEL ADHESION PREVENTION SOLUTION | Lifecore Biomedical, Inc. | Nov 16, 2001 | APWD |
| [P950034](https://fda.innolitics.com/submissions/OB/OB-misc/MCN/P950034.md) | SEPRAFILM(TM) (HAL-F(TM)) BIORESORBABLE MEMBRANE | Baxter Healthcare Corporation | Aug 12, 1996 | APPR |
| [P880047](https://fda.innolitics.com/submissions/OB/OB-misc/MCN/P880047.md) | INTERCEED TC7  ABSORBABLE ADHESION BARRIER | ETHICON, Inc. | Sep 15, 1989 | APPR |

## Top Applicants

- Baxter Healthcare Corp — 1 clearance
- Baxter Healthcare Corporation — 1 clearance
- ETHICON, Inc. — 1 clearance
- Lifecore Biomedical, Inc. — 1 clearance
- Womed Sas — 1 clearance

---

**Source:** [https://fda.innolitics.com/submissions/OB/OB-misc/MCN](https://fda.innolitics.com/submissions/OB/OB-misc/MCN)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com
